Antibody drug conjugates market Industry Analysis and Opportunity and Forecast To 2029
Data Bridge Market Research analyzes that the global Antibody Drug Conjugates (ADC) market, which was USD 4,750.00 Million in 2022, would rocket up to USD 26,040.61 Million by 2030, and is expected to undergo a CAGR of 23.7% during the forecast period. “Antibody-Protein Toxin Conjugates” segment is expected to dominate the target segment of the market owing to the increasing investment in healthcare.In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Browse Related Reports @
Comments
Post a Comment